(Q33970512)

30 July 2017

1 reference

title

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma (English)

1 reference

30 July 2017

Yoneda T

1

1 reference

30 July 2017

Michigami T

2

1 reference

30 July 2017

Yi B

3

1 reference

30 July 2017

Williams PJ

4

1 reference

30 July 2017

Niewolna M

5

1 reference

30 July 2017

Hiraga T

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

30 July 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

30 July 2017

88

1 reference

30 July 2017

2979-2988

1 reference

30 July 2017

12 Suppl

1 reference

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

The clinical course of bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Osteolytic bone metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

A novel orthotopic model of breast cancer metastasis to bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Uracil-tegafur in gastric carcinoma: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2979%3A%3AAID-CNCR13%3E3.0.CO%3B2-U

10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference